19-50409564-G-C

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6

The NM_002691.4(POLD1):​c.2052G>C​(p.Gln684His) variant causes a missense change. The variant allele was found at a frequency of 0.000678 in 1,613,510 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar. Synonymous variant affecting the same amino acid position (i.e. Q684Q) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00043 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00070 ( 1 hom. )

Consequence

POLD1
NM_002691.4 missense

Scores

1
9
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:13B:10

Conservation

PhyloP100: 4.16

Publications

11 publications found
Variant links:
Genes affected
POLD1 (HGNC:9175): (DNA polymerase delta 1, catalytic subunit) This gene encodes the 125-kDa catalytic subunit of DNA polymerase delta. DNA polymerase delta possesses both polymerase and 3' to 5' exonuclease activity and plays a critical role in DNA replication and repair. Alternatively spliced transcript variants have been observed for this gene, and a pseudogene of this gene is located on the long arm of chromosome 6. [provided by RefSeq, Mar 2012]
POLD1 Gene-Disease associations (from GenCC):
  • mandibular hypoplasia-deafness-progeroid syndrome
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG, SUPPORTIVE, LIMITED Submitted by: G2P, Orphanet, Ambry Genetics, Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp
  • POLD1-related polyposis and colorectal cancer syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • colorectal cancer, susceptibility to, 10
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • Polymerase proofreading-related adenomatous polyposis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • immunodeficiency 120
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
  • non-severe combined immunodeficiency due to polymerase delta deficiency
    Inheritance: AR Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.10002822).
BP6
Variant 19-50409564-G-C is Benign according to our data. Variant chr19-50409564-G-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 239269.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002691.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLD1
NM_002691.4
MANE Select
c.2052G>Cp.Gln684His
missense
Exon 17 of 27NP_002682.2P28340
POLD1
NM_001308632.1
c.2130G>Cp.Gln710His
missense
Exon 16 of 26NP_001295561.1M0R2B7
POLD1
NM_001256849.1
c.2052G>Cp.Gln684His
missense
Exon 17 of 27NP_001243778.1P28340

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
POLD1
ENST00000440232.7
TSL:1 MANE Select
c.2052G>Cp.Gln684His
missense
Exon 17 of 27ENSP00000406046.1P28340
POLD1
ENST00000595904.6
TSL:1
c.2130G>Cp.Gln710His
missense
Exon 17 of 27ENSP00000472445.1M0R2B7
POLD1
ENST00000599857.7
TSL:1
c.2052G>Cp.Gln684His
missense
Exon 17 of 27ENSP00000473052.1P28340

Frequencies

GnomAD3 genomes
AF:
0.000427
AC:
65
AN:
152270
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000565
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000705
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000440
AC:
110
AN:
249976
AF XY:
0.000428
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000347
Gnomad ASJ exome
AF:
0.000398
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000832
Gnomad NFE exome
AF:
0.000657
Gnomad OTH exome
AF:
0.000328
GnomAD4 exome
AF:
0.000704
AC:
1029
AN:
1461122
Hom.:
1
Cov.:
32
AF XY:
0.000658
AC XY:
478
AN XY:
726898
show subpopulations
African (AFR)
AF:
0.000179
AC:
6
AN:
33480
American (AMR)
AF:
0.000470
AC:
21
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.000574
AC:
15
AN:
26128
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86254
European-Finnish (FIN)
AF:
0.000626
AC:
33
AN:
52700
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5764
European-Non Finnish (NFE)
AF:
0.000824
AC:
916
AN:
1111992
Other (OTH)
AF:
0.000629
AC:
38
AN:
60388
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
60
120
179
239
299
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
40
80
120
160
200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000427
AC:
65
AN:
152388
Hom.:
0
Cov.:
32
AF XY:
0.000510
AC XY:
38
AN XY:
74524
show subpopulations
African (AFR)
AF:
0.000168
AC:
7
AN:
41594
American (AMR)
AF:
0.000261
AC:
4
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.000565
AC:
6
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000705
AC:
48
AN:
68044
Other (OTH)
AF:
0.00
AC:
0
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.531
Heterozygous variant carriers
0
4
8
11
15
19
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000603
Hom.:
0
Bravo
AF:
0.000457
TwinsUK
AF:
0.00135
AC:
5
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.000453
AC:
55
EpiCase
AF:
0.000436
EpiControl
AF:
0.000652

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
6
not provided (8)
-
6
1
Colorectal cancer, susceptibility to, 10 (7)
-
2
2
Hereditary cancer-predisposing syndrome (4)
-
2
-
not specified (2)
-
-
1
Hereditary cancer (1)
-
1
-
POLD1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.47
BayesDel_addAF
Benign
-0.37
T
BayesDel_noAF
Benign
-0.35
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.25
T
Eigen
Uncertain
0.39
Eigen_PC
Uncertain
0.33
FATHMM_MKL
Uncertain
0.90
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Benign
0.030
D
MetaRNN
Benign
0.10
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Uncertain
2.5
M
PhyloP100
4.2
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
-2.3
N
REVEL
Benign
0.19
Sift
Uncertain
0.028
D
Sift4G
Uncertain
0.033
D
Polyphen
0.73
P
Vest4
0.33
MutPred
0.47
Loss of stability (P = 0.0526)
MVP
0.55
MPC
1.5
ClinPred
0.35
T
GERP RS
2.2
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.8
Varity_R
0.22
gMVP
0.51
Mutation Taster
=44/56
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs144143245; hg19: chr19-50912821; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.